As of May 28
| -0.15 / -0.14%|
The 3 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 115.00, with a high estimate of 125.00 and a low estimate of 96.40. The median estimate represents a +4.55% increase from the last price of 109.99.
The current consensus among 3 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.